Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease

Overview of attention for article published in Respiratory Research, December 2011

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 1 X user

patent: 2 patents

Citations

dimensions_citation: 77 Dimensions

Readers on

mendeley: 108 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist

Grant US-11090294-B2

United States of America

Combination of umeclidinium, fluticasone propionate and salmeterol xinafoate for use in…

Grant US-9795561-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.